Patents Assigned to T-HELPER CELL TECHNOLOGIES, LLC
  • Patent number: 11376283
    Abstract: Aspects of the invention relate to a novel mesenchymal stem cell line (hb-MSC), a culture medium conditioned by the hb-MSC line, and various hb-MSC compositions. The hb-MSC compositions may include a plurality of hb-MSCs, the hb-MSC conditioned medium, or a combination thereof. The hb-MSC compositions may also include one or more of an antimicrobial agent, a film-forming agent, an appropriate carrier, as well as other additives as determined by the application. Also described are methods of use for the hb-MSC cells, the conditioned medium, and the compositions, including methods of treating or preventing bovine mastitis.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: July 5, 2022
    Assignee: T-Helper Cell Technologies, LLC
    Inventors: Anatoliy Andreevich Sokolov, Antonina Ivanovna Kolesnikova, Andrei Igorevich Dovgii, Artem Andreevich Sokolov, Nikolay Vladimirovich Adrianov
  • Publication number: 20200360440
    Abstract: Aspects of the invention relate to a novel mesenchymal stem cell line (hb-MSC), a culture medium conditioned by the hb-MSC line, and various hb-MSC compositions. The hb-MSC compositions may include a plurality of hb-MSCs, the hb-MSC conditioned medium, or a combination thereof. The hb-MSC compositions may also include one or more of an antimicrobial agent, a film-forming agent, an appropriate carrier, as well as other additives as determined by the application. Also described are methods of use for the hb-MSC cells, the conditioned medium, and the compositions, including methods of treating or preventing bovine mastitis.
    Type: Application
    Filed: May 31, 2017
    Publication date: November 19, 2020
    Applicant: T-HELPER CELL TECHNOLOGIES, LLC
    Inventors: Anatoliy Andreevich SOKOLOV, Antonina Ivanovna KOLESNIKOVA, Andrei Igorevich DOVGII, Artem Andreevich SOKOLOV, Nikolay Vladimirovich ADRIANOV
  • Patent number: 10744160
    Abstract: Aspects of the invention relate to a novel mesenchymal stem cell line (hb-MSC), a culture medium conditioned by the hb-MSC line, and various hb-MSC compositions. The hb-MSC composition may include a plurality of hb-MSCs, an hb-MSC conditioned medium, or a combination thereof. The hb-MSC composition may also include an appropriate carrier. Also described are methods of use for the hb-MSC cells, the conditioned medium and compositions thereof.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: August 18, 2020
    Assignee: T-Helper Cell Technologies, LLC
    Inventors: Anatoliy Sokolov, Antonina Ivanovna Kolesnikova, Andrei Igorevich Dovgii
  • Publication number: 20170326178
    Abstract: Aspects of the invention relate to a novel mesenchymal stem cell line (hb-MSC), a culture medium conditioned by the hb-MSC line, and various hb-MSC compositions. The hb-MSC composition may include a plurality of hb-MSCs, an hb-MSC conditioned medium, or a combination thereof. The hb-MSC composition may also include an appropriate carrier. Also described are methods of use for the hb-MSC cells, the conditioned medium and compositions thereof.
    Type: Application
    Filed: November 30, 2015
    Publication date: November 16, 2017
    Applicant: T-HELPER CELL TECHNOLOGIES, LLC
    Inventors: Anatoliy SOKOLOV, Antonina Ivanovna KOLESNIKOVA, Andrei Igorevich DOVGII